Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» remdesivir
remdesivir
Gilead will test remdesivir in children with COVID-19
Pharmaforum
Thu, 06/18/20 - 10:34 am
Gilead Sciences
remdesivir
pediatric
clinical trials
COVID-19
Gilead files remdesivir for EU approval, with a verdict possible “in weeks”
Pharmaforum
Tue, 06/9/20 - 10:36 am
EMA
Europe
Gilead Sciences
remdesivir
COVID-19
Could Gilead's COVID-19 Drug Make $7 Billion Per Year?
Motley Fool
Sun, 06/7/20 - 10:25 pm
Gilead Sciences
COVID-19
remdesivir
Gilead's next step on coronavirus: inhaled remdesivir, other easier-to-use versions
Reuters
Tue, 06/2/20 - 11:19 pm
Gilead Sciences
drug development
remdesivir
COVID-19
Gilead’s remdesivir shows some benefit in patients with moderate Covid-19, new data show
Stat
Mon, 06/1/20 - 10:32 am
Gilead Sciences
remdesivir
COVID-19
Roche and Gilead Launch COVID-19 Trial to Test One-Two Punch of Actemra and Remdesivir
BioSpace
Thu, 05/28/20 - 10:59 pm
Roche
Gilead Sciences
clinical trials
Actemra
RoActemra
remdesivir
COVID-19
pneumonia
COVID-19 pneumonia
UK grants early access for Gilead’s remdesivir in Covid-19
MedCity News
Thu, 05/28/20 - 10:37 am
UK
Gilead Sciences
remdesivir
COVID-19
Bangladesh pharma claims to be first to launch generic remdesivir
BioPharma Dive
Thu, 05/21/20 - 11:08 pm
Bangladesh
Beximco
generics
remdesivir
Gilead Sciences
COVID-19
Covid-19 has exposed the limits of the pharmaceutical market model
Stat
Wed, 05/20/20 - 11:26 pm
pharma marketing
Gilead Sciences
remdesivir
COVID-19
drug development
pandemics
Biosig cleared to test merimepodib plus remdesivir in COVID-19
Pharmaforum
Wed, 05/20/20 - 10:28 am
BioSig Technologies
ViralClear
FDA
clinical trials
merimepodib
COVID-19
remdesivir
antivirals
Gilead ups its donation of the Covid-19 drug remdesivir for U.S. hospitals
Stat
Mon, 05/18/20 - 11:09 pm
Gilead Sciences
COVID-19
remdesivir
federal government
Why Gilead's Remdesivir Might Not Be the Mega-Moneymaker Some Think It Will Be
Motley Fool
Mon, 05/18/20 - 11:10 am
Gilead Sciences
remdesivir
COVID-19
Where Will Gilead Sciences Be in 1 Year?
Motley Fool
Wed, 05/13/20 - 11:15 am
Gilead Sciences
remdesivir
COVID-19
pandemic
Gilead inks deals with generics makers to supply COVID-19 therapy remdesivir for 127 countries
Fierce Pharma
Tue, 05/12/20 - 05:16 pm
Gilead Sciences
generics
drug manufacturing
COVID-19
remdesivir
With little data, doctors struggle to decide which Covid-19 patients should get remdesivir
Stat
Tue, 05/12/20 - 12:05 pm
Gilead Sciences
remdesivir
physicians
pandemic
patients
COVID-19
Inside the NIH’s controversial decision to stop its big remdesivir study
Stat
Mon, 05/11/20 - 10:24 am
Gilead Sciences
remdesivir
NIH
clinical trials
COVID-19
pandemic
Trump administration: States to decide which hospitals gets Gilead's COVID-19 drug
BioPharma Dive
Mon, 05/11/20 - 10:12 am
Donald Trump
pandemic
Gilead Sciences
remdesivir
COVID-19
Early missteps, transparency questions dog U.S. government's remdesivir rollout: reports
Fierce Pharma
Sun, 05/10/20 - 12:03 am
Gilead Sciences
FDA
remdesivir
pandemic
COVID-19
The U.S. government contributed research to a Gilead remdesivir patent — but didn’t get credit
Stat
Fri, 05/8/20 - 10:29 am
Gilead Sciences
remdesivir
federal government
patents
R&D
Japan approves Gilead Sciences' remdesivir as COVID-19 drug
Reuters
Thu, 05/7/20 - 10:32 pm
Japan
Gilead Sciences
COVID-19
remdesivir
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »